Literature DB >> 7439983

Improved protection against cholera in adult rabbits with a combined flagellar-toxoid vaccine.

I G Resnick, C W Ford, G M Shackleford, L J Berry.   

Abstract

Ligated ileal loops of adult rabbits were used to evaluate the prophylactic potential against cholera of a combined vaccine consisting of toxin-free crude flagella (CF) and glutaraldehyde-derived cholera toxoid (TV). The resulting fluid accumulation ratios were compared with those in rabbits immunized with saline (controls) and with CF and TV alone. Data for single vaccines confirmed the superior protection effect of CF over TV. In rabbits vaccinated with both CF and TV, maximal fluid accumulation ratios were not obtained with a challenge dose as high as 5 X 10(9) colony-forming units (CFU). Two rabbits similarly immunized failed to produce positive loops with challenges of 6.3 X 10(8) and 5 X 10(9) CFU, respectively. The vibriocidal titer of serum from rabbits immunized with a killed commercial vaccine in addition to those listed above was determined at intervals for a period of 164 days. No vibriocidal activity was detected in serum of control rabbits and of rabbits vaccinated with TV. Serum from animals given CF or commercial vaccine had similar vibriocidal titers even when the test bacteria were nonflagellated. Protection against challenge as evaluated by ileal loops did not, however, correlate with vibriocidal titer.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7439983      PMCID: PMC551321          DOI: 10.1128/iai.30.2.375-380.1980

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  20 in total

Review 1.  Thymus-independent B-cell induction and paralysis.

Authors:  A Coutinho; G Möller
Journal:  Adv Immunol       Date:  1975       Impact factor: 3.543

2.  Induction of steroidogenesis in tissue culture by cholera enterotoxin.

Authors:  S T Donta; M King; K Sloper
Journal:  Nat New Biol       Date:  1973-06-20

3.  The 1968-1969 cholera-vaccine field trial in rural East Pakistan. Effectiveness of monovalent Ogawa and Inaba vaccines and a purified Inaba antigen, with comparative results of serological and animal protection tests.

Authors:  W H Mosley; W E Woodward; K M Aziz; A S Rahman; A K Chowdhury; A Ahmed; J C Feeley
Journal:  J Infect Dis       Date:  1970-05       Impact factor: 5.226

4.  Antitoxic immunity in experimental cholera: comparison of immunity induced perorally and parenterally in mice.

Authors:  K Fujita; R A Finkelstein
Journal:  J Infect Dis       Date:  1972-06       Impact factor: 5.226

5.  Protection of infant mice against cholera by antibodies to three antigens of Vibrio cholerae.

Authors:  S H Neoh; D Rowley
Journal:  J Infect Dis       Date:  1972-07       Impact factor: 5.226

6.  A serological survey for cholear antibodies in rural east Pakistan. 1. The distribution of antibody in the control population of a cholera-vaccine field-trial area and the relation of antibody titre to the pattern of endemic cholera.

Authors:  W H Mosley; A S Benenson; R Barui
Journal:  Bull World Health Organ       Date:  1968       Impact factor: 9.408

7.  A serological survey for cholera antibodies in rural east Pakistan. 2. A comparison of antibody titres in the innunized and control populationd of a cholera-vaccine field-trial area and the relation of antibody titre to cholera case rate.

Authors:  W H Mosley; A S Benenson; R Barui
Journal:  Bull World Health Organ       Date:  1968       Impact factor: 9.408

8.  Motility as a virulence factor for Vibrio cholerae.

Authors:  M N Guentzel; L J Berry
Journal:  Infect Immun       Date:  1975-05       Impact factor: 3.441

9.  Antitoxic immunity in experimental cholera: protection, and serum and local antibody responses in rabbits after enteral and parenteral immunization.

Authors:  J Holmgren; A M Svennerholm; O Ouchterlony; A Anderson; G Walletström; U Westerberg-Berndtsson
Journal:  Infect Immun       Date:  1975-12       Impact factor: 3.441

10.  Serological studies in cholera. 2. The vibriocidal antibody response of cholera patients determined by a microtechnique.

Authors:  A S Benenson; A Saad; W H Mosley
Journal:  Bull World Health Organ       Date:  1968       Impact factor: 9.408

View more
  9 in total

1.  Common and specific epitopes of Campylobacter flagellin recognized by monoclonal antibodies.

Authors:  I Nachamkin; A M Hart
Journal:  Infect Immun       Date:  1986-08       Impact factor: 3.441

Review 2.  New knowledge on pathogenesis of bacterial enteric infections as applied to vaccine development.

Authors:  M M Levine; J B Kaper; R E Black; M L Clements
Journal:  Microbiol Rev       Date:  1983-12

3.  Safety, immunogenicity, and efficacy against cholera challenge in humans of a typhoid-cholera hybrid vaccine derived from Salmonella typhi Ty21a.

Authors:  C O Tacket; B Forrest; R Morona; S R Attridge; J LaBrooy; B D Tall; M Reymann; D Rowley; M M Levine
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

4.  Identification and occurrence of Vibrio cholerae flagellar core proteins in isolated outer membrane.

Authors:  K Richardson; C D Parker
Journal:  Infect Immun       Date:  1985-03       Impact factor: 3.441

5.  Flagellar preparations from Pseudomonas aeruginosa: isolation and characterization.

Authors:  T C Montie; R C Craven; I A Holder
Journal:  Infect Immun       Date:  1982-01       Impact factor: 3.441

6.  Effect of chemical and heat inactivation on the antigenicity and immunogenicity of Vibrio cholerae.

Authors:  S J Cryz; E Fürer; R Germanier
Journal:  Infect Immun       Date:  1982-10       Impact factor: 3.441

7.  Roles of motility and flagellar structure in pathogenicity of Vibrio cholerae: analysis of motility mutants in three animal models.

Authors:  K Richardson
Journal:  Infect Immun       Date:  1991-08       Impact factor: 3.441

8.  Bacteria-immune system interactions. V. Escherichia coli cell-wall components involved in binding to lymphocytes.

Authors:  R K Shockley; R Kleinman
Journal:  Med Microbiol Immunol       Date:  1983       Impact factor: 3.402

9.  Protection in rabbits induced by the Texas Star-SR attenuated A-B+ mutant candidate live oral cholera vaccine.

Authors:  M Boesman-Finkelstein; R A Finkelstein
Journal:  Infect Immun       Date:  1982-04       Impact factor: 3.441

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.